三例心内膜炎患者MRSA菌株达托霉素耐药与异质性耐药的宿主内进化
本研究对3例达托霉素治疗期间出现突破性菌血症的感染性心内膜炎患者的系列MRSA菌株进行全基因组测序、分子分型和突变筛查,并评估异质性耐药与适应度代价。菌株属ST5、ST59和ST4513,达托霉素暴露后MIC升高,耐药株出现mprF和yycH突变;达托霉素敏感株中存在异质性耐药亚群且无明显适应度代价。结论提示不同谱系MRSA在达托霉素暴露后可快速出现异质性耐药和耐药。
要点
- 达托霉素治疗MRSA心内膜炎期间可快速出现异质性耐药和耐药。
- 耐药株携带mprF和yycH突变,异质性耐药亚群无明显适应度代价。
- 不同ST型MRSA均可经达托霉素暴露筛选出耐药。
核心结论
- 不同谱系MRSA菌株在达托霉素暴露后可快速出现异质性耐药和耐药。
研究设计与样本
- 研究纳入3例达托霉素治疗期间出现突破性菌血症的感染性心内膜炎患者的系列MRSA菌株。
- 采用全基因组测序、分子分型和突变筛查分析菌株,并用群体分析和生长曲线评估异质性耐药与适应度代价。
主要发现
- 系列MRSA菌株属于ST5、ST59和ST4513。
- 达托霉素暴露后这些MRSA菌株的达托霉素最低抑菌浓度升高。
- 达托霉素耐药株出现mprF和yycH突变。
- 群体分析显示达托霉素敏感MRSA菌株中存在达托霉素异质性耐药亚群。
- 这些异质性耐药MRSA克隆未观察到显著适应度代价。
临床怎么用
- 对达托霉素治疗MRSA心内膜炎出现突破性菌血症者,应警惕异质性耐药和耐药。
- 达托霉素暴露后需关注菌株MIC变化及mprF、yycH突变。
局限性
- 研究仅基于3例心内膜炎患者的系列MRSA菌株,样本量有限。
- 达托霉素耐药机制仍需进一步研究以完全阐明。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Daptomycin is considered an important alternative for the treatment of methicillin-resistant Staphylococcus aureus (MRSA). However, treatment failures associated with daptomycin nonsusceptibility isolates have been reported in recent years. METHODS: In this study, we investigated serial MRSA strains from 3 endocarditis patients who had breakthrough bacteremia, despite treatment with daptomycin. The strains were analyzed by whole-genome sequencing, molecular typing, and mutation screening. Population analysis and growth curves were also applied to evaluate heteroresistance and fitness cost. RESULTS: This series of MRSA strains belonged to ST5, ST59, and ST4513. The daptomycin minimum inhibitory concentrations for these MRSA strains increased after daptomycin exposure, whereas daptomycin-resistant strains emerged with mutations in mprF and yycH. Population analysis profiling results demonstrated the presence of a daptomycin-heteroresistant subpopulation among daptomycin-susceptible MRSA strains, and no significant fitness cost was observed within these heteroresistant MRSA clones. CONCLUSIONS: We confirmed that daptomycin heteroresistance and resistance could emerge rapidly in MRSA strains of different lineages after daptomycin exposure. Further studies to fully understand the mechanism(s) underlying daptomycin resistance in MRSA are required.
引用
- Ji S, Jiang S, Wei X, et al. In-Host Evolution of Daptomycin Resistance and Heteroresistance in Methicillin-Resistant Staphylococcus aureus Strains From Three Endocarditis Patients. J Infect Dis. 2020. PMID: 32176794. doi:10.1093/infdis/jiz571
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。